Back to News
Market Impact: 0.2
Flow Technology partners with BW Forsyth Partners to Meet Growing Demand for Biopharmaceutical Manufacturing
Source: Newswire
Private Markets & VentureHealthcare & BiotechTechnology & Innovation
An investment in Flow Technology is intended to expand its capacity to support pharmaceutical and biotechnology manufacturers facing more complex production requirements. The funding is positioned as enabling growth in biopharma manufacturing services, though no investment amount, financial terms, or operating targets were disclosed.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.30
More News
- OpenAI Trims Target Value & Volvo Cars Cuts 2,500 Jobs
- The mobile ambitions of SpaceX see telecom stocks get hit again. What the latest developments mean.
- OpenAI nears up to $30 billion funding round at $1.25 trillion valuation led by UAE investors
- Moderna shares plunge after leak of partial cancer vaccine data
- 8 Things to Know About the iPhone Duo
- Musk's clash with Ukraine accelerates demand for Starlink alternatives. Few exist